About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [557 citations: 1–100 of 553 articles]

Articles published in Chemotherapy Research and Practice have been cited 557 times. The following is a list of the 553 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Majid Avijgan, Mahsa Alinaghian, and Masoud Hafizi Esfahani, “Aloe Vera Gel as a Traditional and Complementary Method for Chronic Skin Burn: A Case Report,” Advances in Infectious Diseases, vol. 07, no. 01, pp. 19–25, 2017. View at Publisher · View at Google Scholar
  • Lanshuang Hu, Shengqiang Hu, Linyan Guo, Congcong Shen, Minghui Yang, and Avraham Rasooly, “DNA Generated Electric Current Biosensor,” Analytical Chemistry, 2017. View at Publisher · View at Google Scholar
  • Lisanne Verhoef, David Baartz, Shona Morrison, Karen Sanday, and Andrea Janet Garrett, “Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC),” Australian and New Zealand Journal of Obstetrics and Gynaecology, 2017. View at Publisher · View at Google Scholar
  • Li Hui Tan, Peter H Sykes, Maan M Alkaisi, and John J Evans, “Cell-like features imprinted in the physical nano- and micro-topography of the environment modify the responses to anti-cancer drugs of endometrial cancer cells,” Biofabrication, vol. 9, no. 1, pp. 015017, 2017. View at Publisher · View at Google Scholar
  • Zuhal Hamurcu, Nermin Kahraman, Ahmed Ashour, and Bulent Ozpolat, “FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer,” Breast Cancer Research and Treatment, 2017. View at Publisher · View at Google Scholar
  • Jukapun Yoodee, Unchalee Permsuwan, and Mantiwee Nimworapan, “Efficacy and safety of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis,” Critical Reviews in Oncology/Hematology, vol. 112, pp. 113–125, 2017. View at Publisher · View at Google Scholar
  • Stefano Giovagnoli, Aurelie Schoubben, and Maurizio Ricci, “The long and winding road to inhaled TB therapy: not only the bug’s fault,” Drug Development and Industrial Pharmacy, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Ashenafi Genanew Desta, Mohammedbrhan Abdelwuhab, Wondmagegn Tamiru Tadesse, and Abyot Endale Gurmu, “In vitro antibacterial activities of the leaf extracts of Aloe macrocarpa Tod (Aloaceae),” European Journal of Integrative Medicine, vol. 12, pp. 74–78, 2017. View at Publisher · View at Google Scholar
  • Heidi M. Kieler-Ferguson, Darren Chan, Jonathan Sockolosky, Lydia Finney, Evan Maxey, Stefan Vogt, and Francis C. Szoka, “Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids,” European Journal of Pharmaceutical Sciences, 2017. View at Publisher · View at Google Scholar
  • Yun Cai, Boxin Zhao, Qianying Liang, Yunqi Zhang, Jieying Cai, and Guofeng Li, “The selective effect of Glycyrrhizin and Glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells,” European Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Rafael Llombart-Blanco, Carlos Villas, Álvaro Silva, Azucena Aldaz, Iñigo Navarro, Jeronimo Forteza, Salvador Martin Algarra, and Matías Alfonso, “Local and systemic diffusion of antineoplastic drugs following vertebroplasty using acrylic cement mixed with cisplatin or methotrexate: experimental study in pigs,” European Spine Journal, 2017. View at Publisher · View at Google Scholar
  • Tess M. E. Derksen, Martijn J. L. Bours, Floortje Mols, and Matty P. Weijenberg, “Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–14, 2017. View at Publisher · View at Google Scholar
  • Yuki Mochida, Horacio Cabral, and Kazunori Kataoka, “Polymeric micelles for targeted tumor therapy of platinum anticancer drugs,” Expert Opinion on Drug Delivery, pp. 1–16, 2017. View at Publisher · View at Google Scholar
  • Atefeh Taherian Fard, and Mark A. Ragan, “Modeling the Attractor Landscape of Disease Progression: a Network-Based Approach,” Frontiers in Genetics, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Nicolas Kerckhove, Aurore Collin, Sakahlé Condé, Carine Chaleteix, Denis Pezet, and David Balayssac, “Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • B.S. Pruthvishree, O.R. Vinodh Kumar, D.K. Sinha, Y.P.S. Malik, Z.B. Dubal, P.A. Desingu, M. Shivakumar, N. Krishnaswamy, and B.R. Singh, “ Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase ( bla NDM)-producing Escherichia coli in the piglets of organized farms in India ,” Journal of Applied Microbiology, 2017. View at Publisher · View at Google Scholar
  • Reza Nedaeinia, Amir Avan, Mehdi Ahmadian, Sasan Nedaee Nia, Maryam Ranjbar, Mohammadreza Sharifi, Mohammad Goli, Ahmad Piroozmand, Esmail Nourmohammadi, Mostafa Manian, Gordon A. Ferns, Majid Ghayour-Mobarhan, and Rasoul Salehi, “Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Darya B. Rose, Dave Nellesen, Maureen P. Neary, and Beilei Cai, “Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic,” Journal of Medical Economics, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Roberto Jose Diaz, Sheikh Ali, Mehreen Gull Qadir, Macarena I. De La Fuente, Michael E. Ivan, and Ricardo J. Komotar, “The role of bevacizumab in the treatment of glioblastoma,” Journal of Neuro-Oncology, 2017. View at Publisher · View at Google Scholar
  • Ilja Bobylev, Abhijeet R. Joshi, Mohammed Barham, Wolfram F. Neiss, and Helmar C. Lehmann, “Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • John S. Schardt, Jinan M. Oubaid, Sonya C. Williams, James L. Howard, Chloe M. Aloimonos, Michelle L. Bookstaver, Tek N. Lamichhane, Sonja Sokic, Mariya S. Liyasova, Maura O’Neill, Thorkell Andresson, Arif Hussain, Stanley Lipkowitz, and Steven M. Jay, “Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Petronela Imreova, Jana Feruszova, Stanislav Kyzek, Kristina Bodnarova, Martina Zduriencikova, Katarina Kozics, Pavel Mucaji, Eliska Galova, Andrea Sevcovicova, Eva Miadokova, and Ivan Chalupa, “Hyperforin Exhibits Antigenotoxic Activity on Human and Bacterial Cells,” Molecules, vol. 22, no. 1, pp. 167, 2017. View at Publisher · View at Google Scholar
  • Daniel F. Carr, Seyoum Ayehunie, Andrea Davies, Carrie A. Duckworth, Stephanie French, Neil Hall, Syed Hussain, Howard R. Mellor, Alan Norris, B. Kevin Park, Alexander Penrose, D. Mark Pritchard, Chris S. Probert, Shashi Ramaiah, Claire Sadler, Michael Schmitt, Alison Shaw, James E. Sidaway, Robert G. Vries, Matthew Wagoner, and Munir Pirmohamed, “Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury,” Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Benjamin Grabowski, M. Alexander Schmidt, and Christian Rüter, “Immunomodulatory Yersinia outer proteins (Yops) -useful tools for bacteria and humans alike,” Virulence, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Gan Liu, Hongjun Gao, Yixiong Zuo, Xiaowei Zeng, Wei Tao, Hsiang-i Tsai, and Lin Mei, “DACHPt-Loaded Unimolecular Micelles Based on Hydrophilic Dendritic Block Copolymers for Enhanced Therapy of Lung Cancer,” ACS Applied Materials & Interfaces, 2016. View at Publisher · View at Google Scholar
  • Shubham Jain, Sai Rama Krishna Meka, and Kaushik Chatterjee, “Engineering a Piperine Eluting Nanofibrous Patch for Cancer Treatment,” ACS Biomaterials Science & Engineering, 2016. View at Publisher · View at Google Scholar
  • Anna Klimaszewska-Wiśniewska, Marta Hałas-Wiśniewska, Magdalena Izdebska, Maciej Gagat, Alina Grzanka, and Dariusz Grzanka, “Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton,” Acta Histochemica, 2016. View at Publisher · View at Google Scholar
  • Xuli Meng, Yongfeng Li, Hongchao Tang, Weimin Mao, Hongjian Yang, Xiaojia Wang, Xianfeng Ding, and Shangnao Xie, “Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer,” Amino Acids, vol. 48, no. 2, pp. 487–497, 2016. View at Publisher · View at Google Scholar
  • Christian B. Theodotou, Ashish H. Shah, Michael E. Ivan, and Ricardo J. Komotar, “Subdural hematoma in a patient taking imatinib for GIST: a case report and discussion of risk with other chemotherapeutics,” Anti-Cancer Drugs, vol. 27, no. 3, pp. 259–263, 2016. View at Publisher · View at Google Scholar
  • Giovanna Pulcrano, Salvatore Pignanelli, Adriana Vollaro, Matilde Esposito, Vita Dora Iula, Emanuela Roscetto, Amata Amy Soriano, and Maria Rosaria Catania, “Isolation of Enterobacter aerogenes carrying bla(TEM-1) and blaKPC-3 genes recovered from a hospital Intensive Care Unit,” Apmis, vol. 124, no. 6, pp. 516–521, 2016. View at Publisher · View at Google Scholar
  • Kevser Erol, Semra Yigitaslan, Cigdem Unel, Bilgin Kaygisiz, and Engin Yildirim, “Evaluation of Cisplatin Neurotoxicity in Cultured Rat Dorsal Root Ganglia via Cytosolic Calcium Accumulation,” Balkan Medical Journal, vol. 33, no. 2, pp. 144–151, 2016. View at Publisher · View at Google Scholar
  • Amanda Canas, Laura M. Lopez-Sanchez, Jon Penarando, Araceli Valverde, Francisco Conde, Vanessa Hernandez, Elena Fuentes, Chary Lopez-Pedrera, Juan R. de la Haba-Rodriguez, Enrique Aranda, and Antonio Rodriguez-Ariza, “Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab,” Biochimica Et Biophysica Acta-Molecular Basis Of Disease, vol. 1862, no. 4, pp. 601–610, 2016. View at Publisher · View at Google Scholar
  • Chiara Da Pieve, Louis Allott, Carlos D. Martins, Andrew Vardon, Daniela M. Ciobota, Gabriela Kramer-Marek, and Graham Smith, “ Efficient [ 18 F]AlF Radiolabeling of Z HER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors ,” Bioconjugate Chemistry, 2016. View at Publisher · View at Google Scholar
  • Pooja Khandelwal, Sabine Mellor-Heineke, Najibah Rehman, Adam Lane, Kristi Smiley, Joyce Villanueva, Rebecca A. Marsh, Michael S. Grimley, Stella M. Davies, and Alexandra H. Filipovich, “Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients,” Biology Of Blood And Marrow Transplantation, vol. 22, no. 4, pp. 690–697, 2016. View at Publisher · View at Google Scholar
  • Gerhardt J. Boukes, and Maryna van de Venter, “The apoptotic and autophagic properties of two natural occurring prodrugs, hyperoside and hypoxoside, against pancreatic cancer cell lines,” Biomedicine & Pharmacotherapy, vol. 83, pp. 617–626, 2016. View at Publisher · View at Google Scholar
  • Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, and Lana Kandalaft, “Cancer Vaccines in Ovarian Cancer: How Can We Improve?,” Biomedicines, vol. 4, no. 2, pp. 10, 2016. View at Publisher · View at Google Scholar
  • Kyla R. Rodgers, and Richard C. Chou, “Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions,” Biotechnology Advances, 2016. View at Publisher · View at Google Scholar
  • A. J. Nabill Haniff, and Lay-Harn Gam, “Identification of urinary protein biomarkers for tobacco smoking,” Biotechnology And Applied Biochemistry, vol. 63, no. 2, pp. 266–272, 2016. View at Publisher · View at Google Scholar
  • Christina Cho, Carol Horzempa, David Jones, and Paula J. McKeown-Longo, “The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • T. Kredo, K. Mauff, L. Workman, J. S. Van der Walt, L. Wiesner, P. J. Smith, G. Maartens, K. Cohen, and K. I. Barnes, “The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients,” Bmc Infectious Diseases, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Himanshu Pandey, Radha Rani, and Vishnu Agarwal, “Liposome and Their Applications in Cancer Therapy,” Brazilian Archives Of Biology And Technology, vol. 59, 2016. View at Publisher · View at Google Scholar
  • Anna G. Sorace, C. Chad Quarles, Jennifer G. Whisenant, Ariella B. Hanker, J. Oliver McIntyre, Violeta M. Sanchez, and Thomas E. Yankeelov, “Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+breast cancer: preliminary results,” Breast Cancer Research And Treatment, vol. 155, no. 2, pp. 273–284, 2016. View at Publisher · View at Google Scholar
  • Guy T. Clifton, Victor Gall, George E. Peoples, and Elizabeth A. Mittendorf, “Clinical Development of the E75 Vaccine in Breast Cancer,” Breast Care, vol. 11, no. 2, pp. 116–121, 2016. View at Publisher · View at Google Scholar
  • Anna Klimaszewska-Wisniewska, Marta Halas-Wisniewska, Tadeusz Tadrowski, Maciej Gagat, Dariusz Grzanka, and Alina Grzanka, “Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small c,” Cancer Cell International, vol. 16, 2016. View at Publisher · View at Google Scholar
  • Quan Zhang, Tianyu Sun, Poming Kang, Kai Qian, Bo Deng, Jinghai Zhou, Ruwen Wang, Bin Jiang, Kun Li, Fang Liu, Shiyang Wu, and Qunyou Tan, “Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR i,” Cancer Chemotherapy And Pharmacology, vol. 77, no. 3, pp. 583–593, 2016. View at Publisher · View at Google Scholar
  • D. A. Fennell, Y. Summers, J. Cadranel, T. Benepal, D. C. Christoph, R. Lal, M. Das, F. Maxwell, C. Visseren-Grul, and D. Ferry, “Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer,” Cancer Treatment Reviews, vol. 44, pp. 42–50, 2016. View at Publisher · View at Google Scholar
  • Kevin Kelley, Jonathan Knisely, Marc Symons, and Rosamaria Ruggieri, “Radioresistance of Brain Tumors,” Cancers, vol. 8, no. 4, pp. 42, 2016. View at Publisher · View at Google Scholar
  • Amanda Rinkenbaugh, and Albert Baldwin, “The NF-κB Pathway and Cancer Stem Cells,” Cells, vol. 5, no. 2, pp. 16, 2016. View at Publisher · View at Google Scholar
  • Sayantan Bhattacharyya, Vasanthakumar Sekar, Biswanath Majumder, Debapriya G Mehrotra, Samir Banerjee, Anup K Bhowmick, Neyaz Alam, Gautam K Mandal, Jaydip Biswas, Pradip K Majumder, and Nabendu Murmu, “CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer,” Cellular Oncology, 2016. View at Publisher · View at Google Scholar
  • Mahmoud Labib, Edward H. Sargent, and Shana O. Kelley, “Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Pradeepkumar L. Patel, Niki K. Rana, Mayurbhai R. Patel, Stephen D. Kozuch, and David Sabatino, “Nucleic Acid Bioconjugates in Cancer Detection and Therapy,” Chemmedchem, vol. 11, no. 3, pp. 252–269, 2016. View at Publisher · View at Google Scholar
  • Pavlos Msaouel, Miao Zhang, and Shi-Ming Tu, “Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • Tiffany Field, “Massage therapy research review,” Complementary Therapies in Clinical Practice, 2016. View at Publisher · View at Google Scholar
  • T. Srikumar, M. Markow, B. Centeno, S. Hoffe, J. Tao, H. Fernandez, J. Strosberg, and D. Shibata, “Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma,” Current Oncology, vol. 23, no. 1, pp. E70–E74, 2016. View at Publisher · View at Google Scholar
  • Diana R. Julie, and Karyn A. Goodman, “Advances in the Management of Anal Cancer,” Current Oncology Reports, vol. 18, no. 3, 2016. View at Publisher · View at Google Scholar
  • Gautham Gampa, Shruthi Vaidhyanathan, Brynna Wilken-Resman, Karen E. Parrish, Svetomir N. Markovic, Jann N. Sarkaria, and William F. Elmquist, “Challenges in the Delivery of Therapies to Melanoma Brain Metastases,” Current Pharmacology Reports, 2016. View at Publisher · View at Google Scholar
  • Alessandro Villa, and Stephen Sonis, “Toxicities Associated with Head and Neck Cancer Treatment and Oncology-Related Clinical Trials,” Current Problems in Cancer, 2016. View at Publisher · View at Google Scholar
  • Franky Chandra, Dendi Sandiono, Unwati Sugiri, Oki Suwarsa, and Hendra Gunawan, “Cutaneous Side Effects and Transepidermal Water Loss To Gefitinib: A Study of 11 Patients,” Dermatology and Therapy, 2016. View at Publisher · View at Google Scholar
  • Wenwu Xiao, Tianhong Li, Fernanda C. Bononi, Diana Lac, Ivy A. Kekessie, Yanlei Liu, Eduardo Sanchez, Anisha Mazloom, Ai-hong Ma, Jia Lin, Jimmy Tran, Kevin Yang, Kit S. Lam, and Ruiwu Liu, “Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of alpha 3 integrin-expressing human,” Ejnmmi Research, vol. 6, 2016. View at Publisher · View at Google Scholar
  • S. Xiao, Q. Mu, Y. Wan, and M. Xue, “Spontaneous renal hemorrhage caused by invasive mole: a case report,” European Journal Of Gynaecological Oncology, vol. 37, no. 3, pp. 417–419, 2016. View at Publisher · View at Google Scholar
  • Philip J. O’Halloran, Thomas Viel, David W. Murray, Lydia Wachsmuth, Katrin Schwegmann, Stefan Wagner, Klaus Kopka, Monika A. Jarzabek, Patrick Dicker, Sven Hermann, Cornelius Faber, Tim Klasen, Michael Schäfers, David O’Brien, Jochen H. M. Prehn, Andreas H. Jacobs, and Annette T. Byrne, “Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. 9, pp. 1673–1683, 2016. View at Publisher · View at Google Scholar
  • Caglar Yildiz, Turgut Kacan, Ozlem Bozoklu Akkar, Savas Karakus, Metin Seker, Selen Baloglu Kacan, Hatice Ozer, and Ali Cetin, “Effect of imatinib on growth of experimental endometriosis in rats,” European Journal Of Obstetrics & Gynecology And Reproductive Biology, vol. 197, pp. 159–163, 2016. View at Publisher · View at Google Scholar
  • Ok-Cheol Jeon, Dong-Hyun Seo, Han-Sung Kim, Youngro Byun, and Jin Woo Park, “Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic eff,” European Journal Of Pharmaceutical Sciences, vol. 82, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Seyedeh Hoda Alavizadeh, Javad Akhtari, Ali Badiee, Shiva Golmohammadzadeh, and Mahmoud Reza Jaafari, “Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models,” Expert Opinion On Drug Delivery, vol. 13, no. 3, pp. 325–336, 2016. View at Publisher · View at Google Scholar
  • Bianca K. Verlinden, Abraham Louw, and Lyn-Marie Birkholtz, “Resisting resistance: is there a solution for malaria?,” Expert Opinion On Drug Discovery, vol. 11, no. 4, pp. 395–406, 2016. View at Publisher · View at Google Scholar
  • Jody C. Chuang, Ameen A. Salahudeen, and Heather A. Wakelee, “Rociletinib, a third generation EGFR tyrosine kinase inhibitor: current data and future directions,” Expert Opinion On Pharmacotherapy, vol. 17, no. 7, pp. 989–993, 2016. View at Publisher · View at Google Scholar
  • Viktor H. Koelzer, Karl Steuer, Ulrike Camenisch Gross, Dieter Zimmermann, Aino Paasinen-Sohns, Kirsten D. Mertz, and Gieri Cathomas, “Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Leonardo Marques da Fonseca, Vanessa Amil da Silva, Leonardo Freire-de-Lima, José Osvaldo Previato, Lucia Mendonça-Previato, and Márcia Alves Marques Capella, “Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Janella Hudson, Teresita Munoz-Antonia, Eric Haura, Doug Cress, Vani N. Simmons, and Gwendolyn P. Quinn, “Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes,” Gene, Cell and Tissue, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar
  • Maddalena Grimaldi, Giada Santin, Violetta Insolia, Veronica Dal Bo, Valeria Maria Piccolini, Paola Veneroni, Sergio Barni, Manuela Verri, Sandra Angelica De Pascali, Francesco Paolo Fanizzi, Graziella Bernocchi, and Maria Grazia Bottone, “[Pt(O,O '-acac)(gamma-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells,” Histochemistry And Cell Biology, vol. 145, no. 5, pp. 587–601, 2016. View at Publisher · View at Google Scholar
  • Manu M. Joseph, Aswathy G., Manojkumar T.K., and Sreelekha T.T., “Galactoxyloglucan-Doxorubicin Nanoparticles Exerts Superior Cytotoxic Effects On Cancer Cells − A Mechanistic And In Silico Approach,” International Journal of Biological Macromolecules, 2016. View at Publisher · View at Google Scholar
  • Jorge E. Toblli, Gabriel Cao, Carlos Rivas, Jorge F. Giani, and Fernando P. Dominici, “Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidat,” International Journal Of Cardiology, vol. 212, pp. 84–91, 2016. View at Publisher · View at Google Scholar
  • Masahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, Hideo Omi, Tatsuya Honda, Fumiharu Miura, Yoshihito Yokoyama, Hideki Tokunaga, Tadao Takano, Tsuyoshi Ohta, Dai Shimizu, Naoki Sato, Shu Soeda, Takafumi Watanabe, Hidekazu Yamada, Hideki Mizunuma, Nobuo Yaegashi, Satoru Nagase, Toru Tase, and Toru Sugiyama, “Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study,” International Journal of Clinical Oncology, vol. 21, no. 4, pp. 735–740, 2016. View at Publisher · View at Google Scholar
  • Wellington Rodrigues, Camila Miguel, Ana Nogueira, Carlos Ueira-Vieira, Tony Paulino, Siomar Soares, Elisabete De Resende, Javier Lazo-Chica, Marcelo Araújo, and Carlo Oliveira, “Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study,” International Journal of Environmental Research and Public Health, vol. 13, no. 9, pp. 918, 2016. View at Publisher · View at Google Scholar
  • Rong Sun, Ye Zhang, Wei Zheng, Quan Tian, Ruifang An, and Yan Xue, “Clinical Characteristics of Gestational Trophoblastic Neoplasia A 15-Year Hospital-Based Study,” International Journal Of Gynecological Cancer, vol. 26, no. 1, pp. 216–221, 2016. View at Publisher · View at Google Scholar
  • Kamal Chamoun, Maya Farah, Georges Araj, Ziad Daoud, Rima Moghnieh, Pascale Salameh, Danielle Saade, Jacques Mokhbat, Emme Abboud, Monzer Hamze, Edmond Abboud, Tamima Jisr, Antoine Haddad, Rita Feghali, Nadim Azar, Mohammad El-Zaatari, Marwan Chedid, Christian Haddad, Mireille Zouain Dib Nehme, Angelique Barakat, and Rola Husni, “Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data,” International Journal Of Infectious Diseases, vol. 46, pp. 64–70, 2016. View at Publisher · View at Google Scholar
  • David Kircher, Mark Silvis, Joseph Cho, and Sheri Holmen, “Melanoma Brain Metastasis: Mechanisms, Models, and Medicine,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1468, 2016. View at Publisher · View at Google Scholar
  • Fa Yang, Weihong Wen, and Weijun Qin, “Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies,” International Journal of Molecular Sciences, vol. 18, no. 1, pp. 48, 2016. View at Publisher · View at Google Scholar
  • Nikolaos Ioanou, Alan M. Sedon, Angus Dalgleish, David Mackintosh, Flavio Solca, and Helmout Modjtahedi, “Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhib,” International Journal Of Oncology, vol. 48, no. 3, pp. 908–918, 2016. View at Publisher · View at Google Scholar
  • Amr S. Abu Lila, Chihiro Kato, Masakazu Fukushima, Cheng-Long Huang, Hiromi Wada, and Tatsuhiro Ishida, “Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft,” International Journal Of Oncology, vol. 48, no. 4, pp. 1399–1407, 2016. View at Publisher · View at Google Scholar
  • Fengming Lan, Yang Yang, Jing Han, Qiaoli Wu, Huiming Yu, and Xiao Yue, “Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-kappa B-dependent pathway downregulating MGMT expression,” International Journal Of Oncology, vol. 48, no. 2, pp. 559–568, 2016. View at Publisher · View at Google Scholar
  • Xiaofen Pan, Rui Meng, Zhonghua Yu, Jingjing Mou, Sha Liu, Ziyi Sun, Zhenwei Zou, Gang Wu, and Gang Peng, “Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression,” International Journal Of Oncology, vol. 48, no. 3, pp. 1073–1084, 2016. View at Publisher · View at Google Scholar
  • Vijay M. Patil, Amit Joshi, Vanita Noronha, Vibhor Sharma, Saurabh Zanwar, Sachin Dhumal, Shubhada Kane, Prathamesh Pai, Anil D’Cruz, Pankaj Chaturvedi, Atanu Bhattacharjee, and Kumar Prabhash, “Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation),” International Journal of Surgical Oncology, vol. 2016, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Zohreh Yousefi, Mansorhe Mottaghi, Alireza Rezaei, and Sedighe Ghasemian, “Abnormal Presentation of Choriocarcinoma and Literature Review,” Iranian Journal of Cancer Prevention, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar
  • Andrea Orthmann, Lisa Peiker, Iduna Fichtner, Annika Hoffmann, Ralf Axel Hilger, and Reiner Zeisig, “Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin Liposomes,” Journal Of Biomedical Nanotechnology, vol. 12, no. 1, pp. 56–68, 2016. View at Publisher · View at Google Scholar
  • Katja Zscheppang, Ina Kurth, Nicole Wachtel, Anna Dubrovska, Leoni A. Kunz-Schughart, and Nils Cordes, “Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells,” Journal Of Cancer, vol. 7, no. 6, pp. 736–745, 2016. View at Publisher · View at Google Scholar
  • Kaitlin A. Doucette, Kelly N. Hassell, and Debbie C. Crans, “Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs,” Journal of Inorganic Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Timothy P. Heffron, “Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer,” Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Oliver Schnell, Jun Thorsteinsdottir, Daniel Felix Fleischmann, Markus Lenski, Wolfgang Abenhardt, Armin Giese, Jörg-Christian Tonn, Claus Belka, Friedrich Wilhelm Kreth, and Maximilian Niyazi, “Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma,” Journal of Neuro-Oncology, 2016. View at Publisher · View at Google Scholar
  • Dominik Jeschek, Gabriele Lhota, Jakob Wallner, and Karola Vorauer-Uhl, “A versatile, quantitative analytical method for pharmaceutical relevant lipids in drug delivery systems,” Journal of Pharmaceutical and Biomedical Analysis, vol. 119, pp. 37–44, 2016. View at Publisher · View at Google Scholar
  • Shohei Yamamoto, Hideki Ono, Kazuhiko Kume, and Masahiro Ohsawa, “Oxaliplatin treatment changes the function of sensory nerves in rats,” Journal Of Pharmacological Sciences, vol. 130, no. 4, pp. 189–193, 2016. View at Publisher · View at Google Scholar
  • Xueguang Lu, Fei Jia, Xuyu Tan, Dali Wang, Xueyan Cao, Jiamin Zheng, and Ke Zhang, “Effective Antisense Gene Regulation via Noncationic, Polyethylene Glycol Brushes,” Journal of the American Chemical Society, 2016. View at Publisher · View at Google Scholar
  • Ye Yuan, Larry Wu, Siqi Shen, Shiyong Wu, and Monica M. Burdick, “Effect of alpha 2,6 sialylation on integrin-mediated adhesion of breast cancer cells to fibronectin and collagen IV,” Life Sciences, vol. 149, pp. 138–145, 2016. View at Publisher · View at Google Scholar
  • James P. Parker, Ziga Ude, and Celine J. Marmion, “Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer,” Metallomics, vol. 8, no. 1, pp. 43–60, 2016. View at Publisher · View at Google Scholar
  • Karina Smorodinsky-Atias, Tal Goshen-Lago, Anat Goldberg-Carp, Dganit Melamed, Alexei Shir, Navit Mooshayef, Jonah Beenstock, Yael Karamansha, Ilona Darlyuk-Saadon, Oded Livnah, Natalie G. Ahn, Arie Admon, and David Engelberg, “Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY p,” Molecular Biology Of The Cell, vol. 27, no. 6, pp. 1026–1039, 2016. View at Publisher · View at Google Scholar
  • Deng Pan, Yifan Zhu, Zhicheng Zhou, Tingting Wang, Harrison You, Changying Jiang, and Xin Lin, “The CBM Complex Underwrites NF-kappa B Activation to Promote HER2-Associated Tumor Malignancy,” Molecular Cancer Research, vol. 14, no. 1, pp. 93–102, 2016. View at Publisher · View at Google Scholar
  • Nicoleta Radu, Aurora Salageanu, and Ciprian Tănăsescu, “Studies regarding the mechanisms involved in tissue regeneration, due to application of biomaterials obtained via biotechnology,” Molecular Crystals and Liquid Crystals, vol. 628, no. 1, pp. 204–212, 2016. View at Publisher · View at Google Scholar
  • Eleni Fitsiou, Gregoria Mitropoulou, Katerina Spyridopoulou, Angeliki Tiptiri-Kourpeti, Manolis Vamvakias, Haido Bardouki, Mihalis Panayiotidis, Alex Galanis, Yiannis Kourkoutas, Katerina Chlichlia, and Aglaia Pappa, “Phytochemical Profile and Evaluation of the Biological Activities of Essential Oils Derived from the Greek Aromatic Plant Species Ocimum basilicum, Mentha spicata, Pimpinella anisum and Fortunella margarita,” Molecules, vol. 21, no. 8, pp. 1069, 2016. View at Publisher · View at Google Scholar
  • V. G. Deepagan, Dong Gil You, Wooram Um, Hyewon Ko, Seunglee Kwon, Ki Young Choi, Gi-Ra Yi, Jun Young Lee, Doo Sung Lee, Kwangmeyung Kim, Ick Chan Kwon, and Jae Hyung Park, “ Long-Circulating Au-TiO 2 Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer ,” Nano Letters, 2016. View at Publisher · View at Google Scholar
  • Michael Ramirez, Satwik Rajaram, Robert J. Steininger, Daria Osipchuk, Maike A. Roth, Leanna S. Morinishi, Louise Evans, Weiyue Ji, Chien-Hsiang Hsu, Kevin Thurley, Shuguang Wei, Anwu Zhou, Prasad R. Koduru, Bruce A. Posner, Lani F. Wu, and Steven J. Altschuler, “Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells,” Nature Communications, vol. 7, 2016. View at Publisher · View at Google Scholar